Researchers Find Neuro Biomarkers to Create Smart Brain Stimulators for Parkinson Treatment

Parkinson's disease is a progressive nervous system disorder that affects movement.

Image credit: University of Houston

Parkinson's disease is a progressive nervous system disorder that affects movement. Symptoms include muscle rigidity, tremors, and changes in speech and gait. After diagnosis, treatments can help relieve symptoms, but there is no cure.

Related Abbott, Medtronic Driving Deep Brain Stimulation Innovation for Parkinson’s Disease

The established treatment for this condition is high-frequency brain stimulation. However, the therapy is imprecise because stimulators can only be programmed clinically and are not adaptable to the fluctuating symptoms of the disease. The key to improving the technology is biomarkers.

Now, researchers at the University of Houston have found neuro biomarkers for Parkinson’s disease that can help create the next generation of “smart” deep brain stimulators, able to respond to specific needs of Parkinson’s disease patients, reports Laurie Fickman of University of Houston.

“We can now make the closed-loop stimulator adaptive to sense a patient’s symptoms, so it can make the adjustments to the fluctuations in real time, and the patient no longer has to wait for weeks or months until the doctor can adjust the device,” said Nuri Ince, associate professor of biomedical engineering. He and doctoral student Musa Ozturk, lead author of the paper, published their findings in Movement Disorders journal.

Ezekiel W. Cullen Building, University of Houston (Image: Wikimedia commons)

The researchers also report a new understanding of the electrophysiology of Parkinson’s disease after examining cross frequency coupling in the subthalamic nucleus of patients with Parkinson’s disease both in the OFF state (before medication) and the ON state (after medication). Coupling, the interaction between the brain waves, has been reported in the past, but its significance and functional role have not been well understood.

Related Graphene to Protect Implantable Neurostimulators in People with Neurological Disorders

“Previous research showed coupling only existed in the basal ganglia of untreated patients and assumed to block the brain from functioning properly,” said Ozturk. “We found that strong coupling also exists in treated patients, though at different frequencies, so in effect we have ‘cleared coupling’s name’ and showed the frequencies involved in coupling impacts whether its effects are negative or positive.”

Sam Draper
August 6, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

AT&T Certifies Telit ME910C1-WW as the Module for its Recently Launched NB-IoT Network

ME910C1-WW is the first module certified by AT&T for its recently launched Narrowband IoT network.

Samsung’s Galaxy Watch Active 2 Will Come in 3 Models and ECG

Samsungs first smartwatch to feature an electrocardiogram heart rate tracker.

Maxim’s New Wrist Worn Platform Allow Developers to Design Highly Precise Health Wearables

A wrist worn platform for designers to develop unique and highly accurate wearable devices.

How Health Wearables Are Improving Patients’ Lives

The proliferation of wearables such as Fitbit to FDA approved medical devices shows that...
Discover more